ImmunoCellular Therapeutics Ltd., which is developing immune-based therapies for the treatment of brain and other cancers, has named Anthony Gringeri as its new chief executive, replacing Andrew Gengos, who is resigning.
Gringeri has been ImmunoCellular's senior vice president of strategic resources since August 2013, and has led the implementation of the company's clinical and regulatory strategies for its candidate cancer treatments, ICT-107 and ICT-121.
Los Angeles-based ImmunoCellular(NYSE…
ImmunoCellular Therapeutics Ltd., which is developing immune-based therapies for the treatment of brain and other cancers, has named Anthony Gringeri as its new chief executive, replacing Andrew Gengos, who is resigning.
Gringeri has been ImmunoCellular's senior vice president of strategic resources since August 2013, and has led the implementation of the company's clinical and regulatory strategies for its candidate cancer treatments, ICT-107 and ICT-121.
Los Angeles-based ImmunoCellular(NYSE…